"Glucuronidase" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
No definition found.
Descriptor ID |
D005966
|
MeSH Number(s) |
D08.811.277.450.426
|
Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Glucuronidase".
Below are MeSH descriptors whose meaning is more specific than "Glucuronidase".
This graph shows the total number of publications written about "Glucuronidase" by people in this website by year, and whether "Glucuronidase" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
2005 | 1 | 0 | 1 |
2007 | 1 | 0 | 1 |
2017 | 8 | 2 | 10 |
2018 | 11 | 2 | 13 |
2019 | 2 | 2 | 4 |
2020 | 2 | 1 | 3 |
2021 | 0 | 1 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Glucuronidase" by people in Profiles.
-
Heparanase as a potential player in SARS-CoV-2 infection and induced coagulopathy. Biosci Rep. 2021 07 30; 41(7).
-
COVID-19-induced endotheliitis: emerging evidence and possible therapeutic strategies. Br J Haematol. 2021 04; 193(1):43-51.
-
Relevance of Heparan Sulfate and Heparanase to Severity of COVID-19 in the Elderly. Semin Thromb Hemost. 2021 06; 47(4):348-350.
-
Sensitive detection and quantification of SARS-CoV-2 by multiplex droplet digital RT-PCR. Eur J Clin Microbiol Infect Dis. 2021 Apr; 40(4):807-813.
-
Increased Plasma Heparanase Activity in COVID-19 Patients. Front Immunol. 2020; 11:575047.
-
Beneficial non-anticoagulant mechanisms underlying heparin treatment of COVID-19 patients. EBioMedicine. 2020 Sep; 59:102969.
-
Amplification of human ß-glucuronidase gene for appraising the accuracy of negative SARS-CoV-2 RT-PCR results in upper respiratory tract specimens. J Med Virol. 2021 01; 93(1):48-50.
-
The relationship between pancreatic cancer and hypercoagulability: a comprehensive review on epidemiological and biological issues. Br J Cancer. 2019 08; 121(5):359-371.
-
Klotho, fibroblast growth factor-23, and the renin-angiotensin system - an analysis from the PEACE trial. Eur J Heart Fail. 2019 04; 21(4):462-470.
-
Emerging Structure-Function Paradigm of Endocrine FGFs in Metabolic Diseases. Trends Pharmacol Sci. 2019 02; 40(2):142-153.